Papandreou, C., Bullò, M., Tinahones, F. J., Martínez-González, M. Á., Corella, D., Fragkiadakis, G. A., . . . Salas-Salvadó, J. (2017). Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial. Nutr Metab (Lond).
Chicago-tyylinen lähdeviittausPapandreou, Christopher, et al. "Serum Metabolites in Non-alcoholic Fatty-liver Disease Development or Reversion; a Targeted Metabolomic Approach Within the PREDIMED Trial." Nutr Metab (Lond) 2017.
MLA-viitePapandreou, Christopher, et al. "Serum Metabolites in Non-alcoholic Fatty-liver Disease Development or Reversion; a Targeted Metabolomic Approach Within the PREDIMED Trial." Nutr Metab (Lond) 2017.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.